U.S. stock futures were in the red with earnings due later from Advanced Micro Devices, Uber, Pfizer and Thomson Reuters.

Michael Burry calls the AI boom a repeat of the 2000 dot-com bust, revealing $1B in bearish bets against Nvidia and Palantir.

Shares of Sarepta Therapeutics Inc. plunged in extended trading Monday after the biotechnology company disclosed ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

The company believes the Food and Drug Administration may deal a setback to one of its investigational therapies.

The ASX 200 has reset to levels seen over a month ago, falling on broad weakness across sectors as the RBA remains hawkish on ...

Biotech stock Alvotech SA (NASDAQ:ALVO) is plummeting to three-year lows, down 29.9% at $5.36 at last check. The FDA declined to approve the company's arthritis drug, sending a list of deficiencies ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Encouraged by the high potato prices during last November’s planting season, Khairul Islam, a farmer from Nabdigonj in Rangpur, invested Tk 10.92 lakh in potato cultivation by borrowing.

Apple recently unveiled new iPad Pros with the latest M5 chipset – those became available last week and are already sporting ...

Stocks finished higher Friday as Amazon's strong quarterly results boosted the Nasdaq, with major indexes ending the week and ...

SPS expects those dynamics to continue in the fourth quarter. The company forecast year-over-year revenue growth of 13% to 14 ...